In Episode 2 of our series on vitamin K deficiency bleeding (VKDB), our host Paul Wirkus, MD, FAAP and two experts, Kristan Scott, MD, MSHP and Sarah Coggins, MD, MSCE explore why intramuscular (IM) vitamin K is recommended for newborns, how current supplementation guidelines were established, and what the evidence tells us about its effectiveness. We compare oral and IM administration, discuss why recommendations vary between countries, and review findings from studies in Denmark, Sweden, and Australia.
The conversation also addresses common questions and misinformation families may encounter online, including the risks of unregulated products and the importance of understanding that there is no FDA-approved over-the-counter vitamin K product for newborn prophylaxis. We discuss why some breastfed infants may remain vulnerable to vitamin K deficiency even after receiving the IM injection and why increasing maternal supplementation to boost vitamin K levels in breast milk is not a reliable substitute for newborn prophylaxis.
This episode provides pediatricians with evidence-based context for discussing vitamin K recommendations with families, addressing common concerns, and explaining why the route of administration matters in protecting newborns from potentially serious complications.
The Virtual Curbside is a podcast of the **American Academy of Pediatrics, Utah Chapter (UTAAP)**, connecting pediatricians and subspecialists through practical, accessible pediatric education. Learn more about UTAAP at aaputah.org.
ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP. Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians.
**AMA Credit Designation Statement**
Kansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.